Skip to content

COMPuter-assisted Self-training to Improve EXecutive Function

Computer-Assisted Self-Training to Improve Executive Function Versus Unspecific Training in Patients After Stroke, Cardiac Arrest or in Parkinson's Disease: a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04229056
Acronym
COMPEX
Enrollment
307
Registered
2020-01-14
Start date
2020-06-01
Completion date
2026-06-30
Last updated
2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Cognitive Dysfunction, Executive Dysfunction, Parkinson Disease, Stroke

Keywords

parkinson disease, stroke, cardiac arrest, executive dysfunction, cognitive dysfunction, computer-based cognitive rehabilitation

Brief summary

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer

Detailed description

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to completing generally cognitively stimulating activities on a computer. A total of 307 patients is expected to be enrolled. All patients will complete a neuropsychological test battery assessing executive functions at inclusion, directly after the eight-week training period and at follow-up three months after the end of the intervention period. Furthermore, all patients will answer questionnaires concerning quality of life and ADL-measures at baseline, after the intervention and at follow-up. All patients will train for a period of 8 weeks, 5 times a week for 60 minutes regardless of their group allocation.

Interventions

BEHAVIORALGeneral computer-based cognitive stimulation

For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation.

CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions.

Sponsors

Rigshospitalet, Denmark
CollaboratorOTHER
University of Glasgow
CollaboratorOTHER
University of Basel
CollaboratorOTHER
Copenhagen Trial Unit, Center for Clinical Intervention Research
CollaboratorOTHER
Hjernesagen
CollaboratorUNKNOWN
Göteborg University
CollaboratorOTHER
Aalborg University Hospital
CollaboratorOTHER
Neurorehabilitering - Kbh, City of Copenhagen
CollaboratorOTHER
Bispebjerg Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Because of the nature of the intervention, masking participants and investigators is not possible. Outcome assessors will be masked to the group allocation of participants.

Intervention model description

Two parallel groups will be included in this study

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* A diagnose of stroke, cardiac arrest or Parkinson's disease. * Aged 18 years or older. * Impaired working memory measured with CABPad working memory test, cut off for inclusion: 5 symbols or less backwards * Computer and internet access at home. * Providing informed consent. Inclusion criteria specific for stroke * Inclusion within 6 months post-stroke * Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed. * Initial stroke severity \>/= NIHSS 3. Inclusion criteria specific for cardiac arrest • Inclusion within 6 months post ictus. Inclusion criteria specific for Parkinson's disease * Clinical diagnosis of PD. * Anti-parkinsonian medical treatment (dopaminergic or other).

Exclusion criteria

* Informed consent not provided * Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator * Not able to participate according to investigator

Design outcomes

Primary

MeasureTime frameDescription
CABPad Working Memory TestAfter the end of the intervention (8 weeks after baseline)Test of working memory. The higher score the better (theoretically infinite score)

Secondary

MeasureTime frameDescription
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)At follow-up visit 3 months after the end of the interventionQuestionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better.
Trail Making ADirectly after the intervention, eight weeks after inclusionTest of processing speed and visual attention. The lower score the better (theoretically infinite score)
Trail Making BDirectly after the intervention, eight weeks after inclusionTest of divided attention, mental flexibility. The lower score the better (theoretically infinite score)
SDMTDirectly after the intervention, eight weeks after inclusionSymbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score)
Phonological verbal fluency testDirectly after the intervention, eight weeks after inclusionTest of verbal phonological fluency. The higher score the better (theoretically infinite score)
Categorical verbal fluency testDirectly after the intervention, eight weeks after inclusionTest of verbal categorical fluency. The higher score the better (theoretically infinite score)
Fear questionnaireDirectly after the intervention, eight weeks after inclusionQuestionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear
CABPad Working Memory Test - 3 months follow-upAt follow-up visit 3 months after end of interventionTest of working memory. The higher score the better (theoretically infinite score)
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)Directly after the intervention, eight weeks after inclusionCognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability.
EuroQol-5 domain (EQ-5D-5L)Directly after the intervention, eight weeks after inclusionQuality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability . Higher score indicates more severe disability. Completed by patient and partner
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinson Disease)Directly after the intervention, eight weeks after inclusionQuality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability.
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinsons Disease)At follow-up visit 3 months after the end of the interventionQuality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability.
ComplianceDirectly after the intervention, eight weeks after inclusionMonitoring of total time spent training in minutes
PHQ-9 (Patient health questionnaire 9)Directly after the intervention, eight weeks after inclusionQuestionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability.
2) visual analogue scale (1-10)Directly after the intervention, eight weeks after inclusionAfter last session: how much they liked doing the training and if they would recommend the intervention to somebody else in their situation. Higher score indicates they liked the training more.
mrs: Modified Rankin ScaleDirectly after the intervention, eight weeks after inclusionQuestionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead): Higher score indicates more severe disability.

Countries

Denmark

Contacts

Primary ContactHanne Christensen, Professor
hanne.krarup.christensen@regionh.dk+45 38 63 50 70
Backup ContactKatrine Sværke, M.Sc. Psych.
katrine.svaerke.schioeler@regionh.dk004521251087

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026